Biosimilar Gene Therapy: Investigational Assessment of Secukinumab Gene Therapy.

Fallah, Ali; Estiri, Hajar; Parrish, Elizabeth; Soleimani, Mansoureh; Zeinali, Sirous; Zadeh-Vakili, Azita

Fallah, Ali; Estiri, Hajar; Parrish, Elizabeth; Soleimani, Mansoureh; Zeinali, Sirous; Zadeh-Vakili, Azita.

Afiliação

Fallah A; Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Estiri H; RNAx Ltd., London, UK.
Parrish E; RNAx Ltd., London, UK.
Soleimani M; RNAx Ltd., London, UK.
Zeinali S; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Zadeh-Vakili A; Molecular Medicine, Pasteur Institute of Iran, Tehran, Iran.Electronic Address:zeinali@pasteur.ac.ir.

Cell J ; 21(4): 433-443, 2020 Jan.

Article em En | MEDLINE | ID: mdl-31376325

Palavras-chave

Gene Therapy; Genetic Vectors; Monoclonal Antibody; Secukinumab; Stem Cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cell J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google